A new study suggests that high doses of vitamin D supplements could help reduce disease activity among multiple sclerosis ...

Treatment with tolebrutinib led to greater confirmed disability improvement at 6 months compared with placebo in patients ...

Walk MS is coming to Soldier Field April 27. Help fight multiple sclerosis. Register now for Walk MS at Soldier Field on ...

MUSETTE trial was designed to determine whether a higher dose of the currently approved OCREVUS IV 600 mg would provide ...

Wright, from Bolton, was diagnosed with a life-changing condition 11 years after she first started experiencing episodes in ...

No added benefits in slowing MS disability progression were found in a study that increased Ocrevus dosing to 2-3 times the ...

Discover how MS patients overcome challenges, raise awareness, and lead fulfilling careers in healthcare. Across the UAE, ...

A new study has found that eating fish could help to slow the progression of multiple sclerosis (MS). We look at the research ...

MS patients may receive less frequent rituximab infusions without increasing their chances of relapse or disease progression, ...

Roche Holdings AG (OTC:RHHBY) on Wednesday announced data from MUSETTE Phase 3 trial of a high dose of Ocrevus (ocrelizumab) ...

Roche said on Wednesday that a trial testing higher doses of its multiple sclerosis drug Ocrevus did not show an efficacy ...

Tom Nolan reviews this week’s research There are so many studies published about vitamin D—about a dozen each day—it’s hard to keep up. One that stands out is a double-blind randomised controlled ...